Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Utero Antidepressants and Neurodevelopmental Outcomes in Kindergarteners

27 Apr 2020

Abstract excerpt

OBJECTIVES: To determine if in utero selective serotonin reuptake inhibitor (SSRI) or selective serotonin norepinephrine inhibitor (SNRI) exposure is associated with developmental vulnerability in kindergarten among children whose mothers were diagnosed with prenatal mood or anxiety disorder. METHODS: Linkable administrative data were used to create a population-based cohort of 266 479 mother-child dyads of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child and Adolescent Psychosocial and Emotional Development
Share to Maternal Mental Health During Pregnancy and Postpartum
Share to Prenatal Substance Exposure Effects

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32341177
DOI: 10.1542/peds.2019-1157

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Utero Antidepressants and Neurodevelopmental Outcomes in KindergartenersPMID 32341177Read ↗

The effects of antenatal depression and SSRI exposure on children: A systematic reviewSemantic proximity Read ↗

Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopmentSemantic proximity Read ↗

Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young childrenSemantic proximity Read ↗

New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing BrainSemantic proximity Read ↗

Treated and untreated maternal prenatal mental health difficulties and neurodevelopmental outcomes in early childhood: results from the ELFE cohortSemantic proximity Read ↗

Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomesSemantic proximity Read ↗

In utero exposure to antiepileptic drugs is associated with learning disabilities among offspringSemantic proximity Read ↗

Maternal ADHD medication use during pregnancy and the risk of ADHD in children: Importance of genetic predispositions and impact of using a sibling analysis.Semantic proximity Read ↗

Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age.Semantic proximity Read ↗

Prenatal depression and 5‐ <scp>HTTLPR</scp> interact to predict dysregulation from 3 to 36 months – A differential susceptibility modelSemantic proximity Read ↗

Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestationSemantic proximity Read ↗

Mental Disorders Among Offspring Prenatally Exposed to Systemic GlucocorticoidsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.